Search Count: 721
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-22 Classification: TRANSFERASE Ligands: 5YK, GOL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-22 Classification: TRANSFERASE Ligands: 5YV, CL, MES |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-22 Classification: TRANSFERASE Ligands: 5YO |
 |
Organism: Saccharomyces cerevisiae (strain atcc 204508 / s288c)
Method: X-RAY DIFFRACTION Release Date: 2025-10-22 Classification: ANTITUMOR PROTEIN Ligands: ZN |
 |
 |
 |
High-Resolution Crystal Structure Of Vibrio Cholerae Nfeob In The Gdp-Bound Form
Organism: Vibrio cholerae
Method: X-RAY DIFFRACTION Release Date: 2025-09-03 Classification: TRANSPORT PROTEIN Ligands: GDP, GOL |
 |
Organism: Vibrio cholerae
Method: X-RAY DIFFRACTION Release Date: 2025-09-03 Classification: TRANSPORT PROTEIN Ligands: GCP, GOL, MG |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBOTOR Ligands: A1L7M |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
 |
Cryo-Em Structure Of 5E10 Fab In Complex With H3 Influenza Singapore 2016 Ha Trimer
Organism: Influenza a virus
Method: ELECTRON MICROSCOPY Release Date: 2025-08-06 Classification: IMMUNE SYSTEM Ligands: NAG |
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) In Complex With The Noncovalently Bound Inhibitor C5N17A
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-07-02 Classification: VIRAL PROTEIN Ligands: DMS, A1IHT, CL, MG |
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) In Complex With The Noncovalently Bound Inhibitor C5N17B
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-07-02 Classification: VIRAL PROTEIN Ligands: DMS, A1IHV, IMD |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-04-23 Classification: RIBOSOME/ANTIBIOTIC Ligands: ZN, MG, ZLD |
 |
Organism: Bacillus thuringiensis
Method: X-RAY DIFFRACTION Resolution:3.11 Å Release Date: 2025-02-12 Classification: TOXIN |
 |
Crystal Structure Of The Spore Gernation Lytic Transglycosylase Slec From Clostridioides Difficile In Its Zymogenic Form (Prepro-Slec)
Organism: Clostridioides difficile 630
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2025-02-12 Classification: HYDROLASE |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-01-22 Classification: IMMUNE SYSTEM |